Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT ONC FATE

| Held by: ARKK ARKG IWM VTI VXF IWN IBB SCHA PRFZ VTWO

Index	RUT	P/E	-	EPS (ttm)	-2.18	Insider Own	10.29%	Shs Outstand	301.85M	Perf Week	4.19%
Market Cap	742.39M	Forward P/E	-	EPS next Y	-0.52	Insider Trans	-0.09%	Shs Float	270.83M	Perf Month	30.80%
Enterprise Value	1.14B	PEG	-	EPS next Q	-0.14	Inst Own	55.16%	Short Float	12.56%	Perf Quarter	21.73%
Income	-502.43M	P/S	4.80	EPS this Y	-65.00%	Inst Trans	-3.63%	Short Ratio	3.95	Perf Half Y	49.94%
Sales	154.58M	P/B	20.57	EPS next Y	71.92%	ROA	-44.60%	Short Interest	34.00M	Perf YTD	31.50%
Book/sh	0.12	P/C	2.48	EPS next 5Y	25.47%	ROE	-205.41%	52W High	2.73 -9.93%	Perf Year	45.50%
Cash/sh	0.99	P/FCF	-	EPS past 3/5Y	-21.38% -23.55%	ROIC	-68.31%	52W Low	0.85 188.92%	Perf 3Y	-78.22%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.67% 11.12%	Gross Margin	-210.02%	Volatility	9.41% 8.50%	Perf 5Y	-93.63%
Dividend TTM	-	EV/Sales	7.40	EPS Y/Y TTM	-16.00%	Oper. Margin	-357.07%	ATR (14)	0.18	Perf 10Y	-80.70%
Dividend Ex-Date	-	Quick Ratio	5.40	Sales Y/Y TTM	-10.72%	Profit Margin	-325.02%	RSI (14)	59.43	Recom	2.20
Dividend Gr. 3/5Y	- -	Current Ratio	6.24	EPS Q/Q	43.24%	SMA20	13.35%	Beta	2.28	Target Price	2.31
Payout	-	Debt/Eq	19.40	Sales Q/Q	-3.82%	SMA50	16.07%	Rel Volume	1.00	Prev Close	2.52
Employees	575	LT Debt/Eq	19.38	Earnings	Nov 05 AMC	SMA200	58.38%	Avg Volume	8.62M	Price	2.46
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	14.02% -4.14%	Trades		Volume	873,261	Change	-2.42%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20
Oct-15-21	Resumed	Cowen	Market Perform	$30

Show Previous Ratings

Jan-23-26 06:15PM	Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts (Zacks)
Jan-16-26 06:15PM	Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know (Zacks) -5.96% +6.79%
Jan-15-26 10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
Jan-12-26 09:15AM	PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases (GlobeNewswire)
09:05AM	PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) (GlobeNewswire)
09:05AM	Loading…
09:05AM	PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire)
Jan-09-26 11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
Jan-08-26 11:01PM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
09:05AM	PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell (GlobeNewswire)
Jan-07-26 06:15PM	Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +5.05%
Jan-05-26 12:23PM	ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure (GuruFocus.com) +7.61%
Jan-02-26 11:01AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
08:00AM	Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 (StockStory)
05:00PM	Loading…
Dec-31-25 05:00PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +8.09%
06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:49PM	Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) (Insider Monkey)
04:05PM	PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-03-25 03:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
Nov-28-25 09:05AM	PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks) -9.13%
Nov-24-25 01:00PM	PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know (StockStory) +12.61%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks) +5.10%
Nov-13-25 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.32%
12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks)
Nov-12-25 03:20PM	Why PacBio (PACB) Shares Are Getting Obliterated Today (StockStory) -6.45%
12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory)
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
10:35PM	Loading…
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory)
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire)
Nov-03-25 10:07PM	PacBio Earnings: What To Look For From PACB (StockStory)
Oct-31-25 02:11PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +20.62%
Oct-28-25 06:15PM	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.74%
Oct-24-25 02:36PM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Oct-22-25 04:05PM	PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire) +5.98%
Oct-21-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know (Zacks)
Oct-20-25 10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks) +20.73%
Oct-14-25 06:15PM	Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) +9.43%
06:05AM	PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities (GlobeNewswire)
Oct-13-25 12:22PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +14.08%
09:05AM	PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project (GlobeNewswire)
Oct-10-25 10:02AM	Here's Why You Should Retain PacBio Stock in Your Portfolio for Now (Zacks) -7.19%
Oct-08-25 12:44PM	PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell (Zacks) +7.86%
11:36AM	Why Is PacBio (PACB) Stock Soaring Today (StockStory)
09:05AM	Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity (GlobeNewswire)
Oct-07-25 09:05AM	PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs (GlobeNewswire) -7.89%
Oct-06-25 06:15PM	Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today (Zacks)
Sep-30-25 10:05AM	PacBio Enters Carrier Screening Market With PureTarget Expansion (Zacks)
Sep-22-25 06:15PM	Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts (Zacks)
09:05AM	PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes (GlobeNewswire)
Sep-19-25 12:03AM	3 Reasons PACB is Risky and 1 Stock to Buy Instead (StockStory)
Sep-15-25 11:46AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Sep-14-25 11:36PM	Life Sciences Tools & Services Stocks Q2 Teardown: PacBio (NASDAQ:PACB) Vs The Rest (StockStory)
Sep-12-25 06:15PM	Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today (Zacks) -7.14%
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
Sep-03-25 09:05AM	PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow (GlobeNewswire)
Aug-22-25 02:25PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +9.52%
Aug-19-25 01:51PM	Cathie Woods ARK Innovation Sees Outflows, But Buys More Deere Stock Anyway (Barrons.com)
Aug-14-25 01:34AM	The Top 5 Analyst Questions From PacBio's Q2 Earnings Call (StockStory)
Aug-13-25 03:01PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +5.79%
Aug-11-25 09:38AM	PACB Q2 Deep Dive: International Demand, Consumables Growth, and Clinical Adoption Drive Results (StockStory) -6.67%
Aug-08-25 12:21PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +7.14%
12:07PM	PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises (Zacks)
Aug-07-25 07:30PM	Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) -8.70%
07:00PM	Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
05:58PM	Pacific Biosciences: Q2 Earnings Snapshot (Associated Press Finance)
05:07PM	PacBio (NASDAQ:PACB) Delivers Strong Q2 Numbers, Stock Soars (StockStory)
04:05PM	PacBio Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-06-25 05:50PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-05-25 11:18PM	PacBio (PACB) Q2 Earnings Report Preview: What To Look For (StockStory)
Aug-04-25 09:15AM	Stay Ahead of the Game With Pacific Biosciences (PACB) Q2 Earnings: Wall Street's Insights on Key Metrics (Zacks)
09:05AM	Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models (GlobeNewswire)
Jul-31-25 12:03AM	3 Reasons to Avoid PACB and 1 Stock to Buy Instead (StockStory) -7.38%
Jul-29-25 06:15PM	Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights (Zacks) -6.10%
03:30PM	PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know (StockStory)
09:35AM	Pacific Biosciences (PACB) Jumps 6.5% Ahead of Earnings (Insider Monkey)
08:52AM	Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing (PR Newswire)
Jul-24-25 09:05AM	PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications (GlobeNewswire) -8.88%
Jul-23-25 01:11PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
09:05AM	PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio (GlobeNewswire)
Jul-22-25 04:05PM	QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels (Business Wire) +11.72%
Jul-21-25 04:05PM	PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire) +5.84%
Jul-17-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks) -6.71%
Jul-10-25 06:15PM	Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Jul-09-25 11:57AM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jul-08-25 12:00PM	Pacific Biosciences (PACB) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jul-03-25 09:08AM	Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue (Insider Monkey) +7.38%
Jun-30-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks)

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Van Oene Mark	See Remarks	Aug 18 '25	Sale	1.31	26,836	35,182	1,920,035	Aug 20 04:06 PM
MARK VAN OENE	Officer	Aug 18 '25	Proposed Sale	1.31	26,836	35,174		Aug 18 04:07 PM
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '25	Sale	1.41	12,497	17,583	2,225,357	Mar 05 04:37 PM
Van Oene Mark	See Remarks	Mar 03 '25	Sale	1.41	6,486	9,126	1,497,695	Mar 05 04:37 PM
Farmer Michele	See Remarks	Mar 03 '25	Sale	1.41	2,973	4,183	184,619	Mar 05 04:36 PM
MARK VAN OENE	Officer	Mar 03 '25	Proposed Sale	1.41	6,486	9,123		Mar 03 05:11 PM
CHRISTIAN HENRY	Officer	Mar 03 '25	Proposed Sale	1.41	12,497	17,578		Mar 03 05:06 PM
Farmer Michele	See Remarks	Feb 18 '25	Sale	1.88	24,349	45,727	187,592	Feb 19 05:00 PM
Van Oene Mark	See Remarks	Feb 18 '25	Sale	1.88	100,773	189,252	1,496,681	Feb 19 04:59 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '25	Sale	1.88	259,909	488,109	2,237,854	Feb 19 04:58 PM
CHRISTIAN HENRY	Officer	Feb 18 '25	Proposed Sale	1.88	259,909	488,109		Feb 18 05:59 PM
MARK VAN OENE	Officer	Feb 18 '25	Proposed Sale	1.88	100,773	189,252		Feb 18 05:56 PM

Open in Screener

MRNA

Moderna Inc

Jan 27 • 09:51AM ET

50.27

+2.28 4.75 %

Healthcare • Biotechnology • USA • NASD

Peers: BNTX NVAX REGN ALNY INCY BMRN SRPT VRTX GILD BIIB

| Held by: VTI RSP VOO VB IVV SPY XBI VBR IBB XLV

Index	S&P 500	P/E	-	EPS (ttm)	-8.06	Insider Own	8.54%	Shs Outstand	391.00M	Perf Week	16.91%
Market Cap	19.64B	Forward P/E	-	EPS next Y	-6.72	Insider Trans	-0.07%	Shs Float	357.38M	Perf Month	53.50%
Enterprise Value	15.87B	PEG	-	EPS next Q	-2.58	Inst Own	69.70%	Short Float	19.12%	Perf Quarter	88.00%
Income	-3.12B	P/S	8.80	EPS this Y	14.59%	Inst Trans	-3.70%	Short Ratio	5.57	Perf Half Y	48.25%
Sales	2.23B	P/B	2.11	EPS next Y	15.18%	ROA	-22.31%	Short Interest	68.32M	Perf YTD	70.46%
Book/sh	23.86	P/C	4.36	EPS next 5Y	20.29%	ROE	-29.32%	52W High	55.20 -8.93%	Perf Year	21.40%
Cash/sh	11.53	P/FCF	-	EPS past 3/5Y	- -42.94%	ROIC	-31.11%	52W Low	22.28 125.63%	Perf 3Y	-74.08%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-43.99% 121.86%	Gross Margin	38.93%	Volatility	9.05% 6.68%	Perf 5Y	-59.83%
Dividend TTM	-	EV/Sales	7.11	EPS Y/Y TTM	-38.95%	Oper. Margin	-155.15%	ATR (14)	2.93	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.73	Sales Y/Y TTM	-56.00%	Profit Margin	-139.61%	RSI (14)	73.34	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.93	EPS Q/Q	-1673.01%	SMA20	28.79%	Beta	1.33	Target Price	36.89
Payout	-	Debt/Eq	0.08	Sales Q/Q	-45.44%	SMA50	56.38%	Rel Volume	1.72	Prev Close	47.99
Employees	5800	LT Debt/Eq	0.07	Earnings	Nov 06 BMO	SMA200	77.52%	Avg Volume	12.28M	Price	50.27
IPO	Dec 07, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	72.79% 10.33%	Trades		Volume	2,135,578	Change	4.75%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-07-26	Resumed	UBS	Neutral	$34
Dec-12-25	Initiated	Jefferies	Hold	$30
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82

Show Previous Ratings

Today 08:55AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Jan-26-26 05:50PM	Moderna (MRNA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
11:15AM	Moderna (MRNA) Stock Pulls Back After Recent Strength (Benzinga)
07:00AM	Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026 (ACCESSWIRE)
Jan-25-26 09:01AM	Hecla Mining, Moderna, And Micron Are Among the Top 10 Large-Cap Gainers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio? (Benzinga)
07:00AM	Loading…
Jan-24-26 07:00AM	MarketBeat Week in Review - 01/19 - 01/23 (MarketBeat)
Jan-23-26 01:55PM	Silver Breaks $101, Intel Stock Plunges 17%: What's Moving Markets Friday? (Benzinga) -6.09%
11:10AM	Stock Market Falls, Recovers On Trump's Greenland Shifts; Intel, Netflix, Tesla Key Movers: Weekly Review (Investor's Business Daily)
Jan-22-26 05:53PM	Baseline characteristics in Moderna cancer vaccine 'misleading': Leerink's Dr. Mani Foroohar (CNBC TV)
05:02PM	These Stocks Are Today's Movers: Intel, GE Aerospace, Moderna, Abbott, Arista Networks, Mobileye, McCormick, and More (Barrons.com)
04:09PM	Moderna Stock Soars. This Has Sparked a Rally. (Barrons.com)
02:31PM	Biotech stocks are among today's winners (MarketWatch)
02:08PM	Dow, S&P 500, Nasdaq rise, mortgage rates tick higher (Yahoo Finance Video)
12:27PM	Can Elevance Offset Rising Expenses in Q4 With Higher Premiums? (Zacks)
11:39AM	MRNA & MRK's Personalized Cancer Therapy Delivers Strong 5-Year Data (Zacks)
10:51AM	Loading…
10:51AM	Moderna Stock Explodes To New 52-Week High: What's Driving The Action? (Benzinga)
09:31AM	Moderna CEO Says Vaccine Scrutiny Curbing Trials (Bloomberg)
08:08AM	Moderna (MRNA) Touches 52-Week High on Strong Clinical Results (Insider Monkey)
06:27AM	Moderna Stock Is Surging. Why a Cancer Vaccine Study Has Sparked a Rally. (Barrons.com)
06:22AM	Moderna extends rally after drug-trial results, and other early market movers (MarketWatch)
06:17AM	Stocks Set to Extend Rally After Trumps Greenland Pivot, U.S. PCE Inflation and GDP Data in Focus (Barchart)
05:19AM	Stock Market Today: S&P 500, Dow Jones Futures Rise As Trump Scales Down EU Tariff Threats-Microsoft, Moderna, Intel In Focus (Benzinga)
03:38AM	Heard on the Street Wednesday Recap: Greenland Tensions Thaw (The Wall Street Journal)
01:03AM	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality (Reuters)
12:01AM	Johnson & Johnson Crushes Patent, Pricing Probs (The Daily Upside)
Jan-21-26 08:23PM	Intel, Moderna, TMC, Microsoft And Lucid: Why These 5 Stocks Are On Investors' Radars Today (Benzinga) +15.84%
07:32PM	Analyst Report: Moderna, Inc. (Morningstar Research)
07:11PM	Why Moderna Stock Surged Today (Motley Fool)
04:46PM	Heard on the Street Recap: Greenland Tensions Thaw (The Wall Street Journal)
03:57PM	Moderna and Merck pop on cancer vaccine, Lucid-Rockwell partnership (Yahoo Finance Video)
02:24PM	Loading…
02:24PM	Moderna Stock Skyrockets To 52-Week High: What's Behind The Surge? (Benzinga)
01:57PM	Stocks Rebound On Trump's Remarks, Natural Gas Rockets: What's Moving Markets Wednesday? (Benzinga)
12:21PM	Moderna (MRNA) Shares Skyrocket, What You Need To Know (StockStory)
10:06AM	Can HCA Q4 Earnings Withstand Higher Costs & Lower Outpatient Cases? (Zacks)
05:38AM	Moderna cancer vaccine holds up; IO Biotech considers a sale (BioPharma Dive)
Jan-20-26 06:00PM	Moderna (MRNA) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
04:21PM	Moderna-Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma (Benzinga)
03:31PM	Moderna Pops 17%-Is There Life in MRNA, Down 90% from COVID High? (MarketBeat)
10:24AM	Analyst Report: Moderna, Inc. (Morningstar Research)
06:58AM	Moderna, Merck Report Positive Results From Cancer-Vaccine Study (The Wall Street Journal)
06:00AM	Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection (ACCESSWIRE)
Jan-18-26 11:35PM	3 Healthcare Stocks Walking a Fine Line (StockStory)
08:31AM	CoreWeave, Moderna, Roblox Are Among the Top 10 Large-Cap Gainers Last Week (Jan. 12-Jan. 16): Are the Others in Your Portfolio? (Benzinga)
Jan-17-26 04:30AM	Investing.coms stocks of the week (Investing.com)
Jan-16-26 12:45PM	I Hope Moderna (MRNA) Posts Growth, Says Jim Cramer (Insider Monkey) +6.28%
08:55AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
08:06AM	Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026 (24/7 Wall St.)
07:07AM	Moderna's Q4 2025 Earnings: What to Expect (Barchart)
03:56AM	This COVID-Era Biotech Favorite Is Surging Once Again On Strong Q4 Guidance: Momentum Score Spikes (Benzinga)
Jan-15-26 08:53AM	Moderna Stock on the Move: What Sparked the 13% Jump in the Past Week? (Zacks)
08:26AM	Why Merck's 32% Rally Isn't Enough to Change the Bearish View (Zacks)
Jan-14-26 05:50PM	Moderna (MRNA) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
07:09AM	Moderna (MRNA) Rockets 17% on Strong Preliminary FY25 Results (Insider Monkey)
04:04AM	BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan (MarketBeat)
Jan-13-26 08:21PM	Intel, Moderna, Adobe, BitMine Immersion And Strategy: Why These 5 Stocks Are On Investors' Radars Today (Benzinga) +17.02%
06:18PM	Markets Book Profits as Q4 Earnings Season Gets Rolling (Zacks)
04:43PM	JPMorgan, Delta, Intel, AMD, Adobe, Moderna, Super Micro, and More Stock Market Movers (Barrons.com)
04:35PM	Stocks Fall on Weakness in Software and Credit Card Companies (Barchart)
04:30PM	Stock Market Today: Dow Sinks As Investors Digest Inflation Data; Moderna Soars (Live Coverage) (Investor's Business Daily)
04:27PM	Adobe stock downgraded, Moderna surges on upbeat guidance (Yahoo Finance Video)
02:57PM	These Stocks Are Todays Movers: JPMorgan, Delta, Intel, AMD, Adobe, Moderna, Super Micro, and More (Barrons.com)
02:24PM	Moderna Stock Gets Healthy Relative Strength Rating Jump (Investor's Business Daily)
01:26PM	Why Moderna Stock Strength Is Only Beginning: Technical Analysis (Barrons.com)
01:04PM	Silver Jumps To $89 After Soft CPI, JPMorgan Falls 3%: What's Moving Markets Tuesday? (Benzinga)
Jan-12-26 05:14PM	These Stocks Are Todays Movers: Capital One, Amex, Citigroup, JPMorgan, Walmart, Moderna, Affirm, and More (Barrons.com)
11:27AM	Why Moderna Stock Is Dropping After Good News (Barrons.com)
10:24AM	Moderna Stock Jumps, Then Turns Negative: What's Happening? (Benzinga)
08:51AM	Moderna Stock Rises. Revenue in 2025 Will Be Higher Than Midpoint of Guidance. (Barrons.com)
07:00AM	Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference (ACCESSWIRE)
Jan-08-26 05:50PM	Moderna (MRNA) Stock Sinks As Market Gains: Here's Why (Zacks) -5.66%
Jan-07-26 09:26AM	Stock Market News for Jan 7, 2026 (Zacks)
08:55AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
08:04AM	Here Are Wednesdays Top Wall Street Analyst Research Calls: Applied Digital, BigBear.ai, Block, Deckers Outdoors, GitLab, Hershey, McDonalds, Moderna, and More (24/7 Wall St.)
04:35AM	My Top 5 Stocks to Buy in Early 2026 (Motley Fool)
03:58AM	Moderna (MRNA) Soars 10.9%: Is Further Upside Left in the Stock? (Zacks)
Jan-06-26 11:12AM	MRNA Stock Jumps on Global Submissions Seeking Nod for Flu Vaccine (Zacks) +10.85%
Jan-05-26 06:44AM	Moderna, searching for a rebound, to seek approval of mRNA flu shot (BioPharma Dive)
Dec-30-25 05:45PM	Moderna (MRNA) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Dec-27-25 10:30AM	Forget Moderna Stock, This is a Much Better Buy (Motley Fool)
Dec-26-25 02:14PM	These Stocks Are Moving the Most Today: Nvidia, Apple, Tesla, Coupang, Micron, Lam Research, Newmont, Moderna, and More (Barrons.com)
01:53PM	Moderna Stock Sees Healthy Relative Strength Rating (Investor's Business Daily)
12:12PM	A Watching-the-Paint-Dry Stock Market, and Why Volatility Will Make a Comeback (Barrons.com)
10:25AM	It's a Risk-Off Day After Christmas on Wall Street (Barrons.com)
10:25AM	Indexes Slip the Day After Christmas. Risk Is Clearly Off. (Barrons.com)
Dec-23-25 05:45PM	Moderna (MRNA) Stock Dips While Market Gains: Key Facts (Zacks) -7.48%
Dec-22-25 08:55AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Dec-19-25 03:16PM	Why Is Moderna (MRNA) Stock Rocketing Higher Today (StockStory) +9.21%
10:10AM	MRNA to Get CEPI Funding for Phase III Study on Pandemic Influenza Jab (Zacks)
04:30AM	Down 80%, Should You Buy the Dip on Moderna? (Motley Fool)
Dec-18-25 01:14PM	Moderna, Inc. (MRNA): A Bull Case Theory (Insider Monkey)
12:32PM	Moderna's $54M Lifeline: Bird Flu Bet Revived After U.S. Pullback (GuruFocus.com)
11:51AM	Why Moderna (MRNA) Stock Is Up Today (StockStory)
09:54AM	Moderna gets funding for H5 pandemic influenza vaccine (BioPharma Dive)
07:00AM	CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate (ACCESSWIRE)
Dec-17-25 01:01PM	Moderna (MRNA) Stock Trades Up, Here Is Why (StockStory)
07:00AM	Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference (ACCESSWIRE)
Dec-16-25 09:55AM	CHMP Backs EU Approval of MRNA's New COVID-19 Vaccine mNexspike (Zacks)
03:03AM	Zombie biotech buyer Xoma to acquire Generation Bio (BioPharma Dive)
Dec-15-25 09:05AM	Amazon and 9 More Stocks to Buy for 2026 (Barrons.com)
07:00AM	EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA) (ACCESSWIRE)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AFEYAN NOUBAR	Director	Dec 11 '25	Option Exercise	10.90	23,853	259,998	27,777	Dec 15 09:00 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Sale	29.48	23,853	703,306	3,924	Dec 15 09:00 AM
Bancel Stephane	Chief Executive Officer	Dec 11 '25	Option Exercise	10.90	688,073	7,499,996	6,181,970	Dec 15 08:59 AM
Flagship Pioneering Inc.	Affiliate	Dec 11 '25	Proposed Sale	29.49	23,853	703,306		Dec 11 04:30 PM
Hussain Abbas	Director	Dec 09 '25	Sale	27.60	504	13,910	1,515	Dec 11 04:16 PM
Hussain Abbas	Director	Dec 09 '25	Proposed Sale	27.60	504	13,910		Dec 09 10:26 AM
Hussain Abbas	Director	Jun 11 '25	Sale	28.00	312	8,736	580	Jun 12 04:22 PM
Hussain Abbas	Director	Jun 11 '25	Proposed Sale	28.00	312	8,736		Jun 11 10:06 AM
Bancel Stephane	Chief Executive Officer	Mar 03 '25	Buy	31.22	160,314	5,004,318	9,210,686	Mar 04 04:27 PM
SAGAN PAUL	Director	Mar 03 '25	Buy	31.76	31,620	1,004,251	312,027	Mar 04 04:24 PM

PACB

Pacific Biosciences of California Inc

MRNA

Moderna Inc

Upgrade your FINVIZ experience